Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PODN | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | GSG2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | NEK7 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | RP4-635E18.9 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | KHSRP | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | RP11-321N4.5 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | METAP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | PLK1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | NDUFAF4 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | FANCD2 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |